Medical Stocks Based on Stock Prediction Algorithm: Returns up to 13.70% in 7 Days

Package Name: Medicine Stocks
Recommended Positions: Long
Forecast Length: 7 Days (06/08/2018 - 06/15/2018)
I Know First Average: 5.54%

Read The Full Forecast

Medical Stocks

Stock Screener Based on Machine Learning: Returns up to 12.73% in 7 Days

Package Name: By Country - Indian Stocks
Recommended Positions: Long
Forecast Length: 7 Days (06/10/2018 - 06/17/2018)
I Know First Average: 5.44%

Read The Full Forecast

Stock Screener

Daily Market Forecast Based on Pattern Recognition: Returns up to 9.54% in 7 Days

Package Name: Mexican Stocks
Recommended Positions: Long
Forecast Length: 7 Days (06/07/2018 - 06/14/2018)
I Know First Average: 5.38%

Read The Full Forecast

Daily Market Forecast

Algotrader Based on Genetic Algorithms: Returns up to 8.14% in 3 Days

Package Name: By Country - Indian Stocks
Recommended Positions: Long
Forecast Length: 3 Days (06/13/2018 - 06/16/2018)
I Know First Average: 4.55%

Read The Full Forecast


FOSL Stock Forecast: Fossil Group Crushes 2018 Expectations As They Progressed Into The Digital Age


This article was written by Grant Goldstein, a Financial Analyst at I Know First


“Wearables will become the world’s best-selling consumer electronics product after smartphones”



  • Q1 Earnings Beat Expectations for the Fourth Straight Quarter
  • New World Fossil Initiative Widens Profits and Strengthens Companies Future
  • Wearable Technology has Unlimited Potential

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

Winning AAXN Stock Forecast: Axon Enterprise’s Business Continues to Expand as They Acquire VieVu

“We’re up against little companies like Motorola and Panasonic and L3, so there’s still a lot of competition, but the fact is we’ve been winning the vast majority of the deals because our system performs really well.” – Rick Smith, Co-founder and CEO of Axon Enterprise, Inc.

Axon Enterprise, Inc., (NASDAQ: AAXN) formerly TASER International Inc., is engaged in development, manufacture and sale of conducted electrical weapons (CEWs) as well as development of connected wearable on-officer cameras for use by law enforcement

Read More

Winning AVXL Stock Forecast: Life Changing Treatment Discoveries and M&A Expectations Add Value to Avanex

“We are looking forward, focusing on executing clinical trials using the inclusion of advanced genomic biomarkers into late-stage CNS precision medicine trials, including our Rett syndrome, Alzheimer’s disease and Parkinson’s disease dementia trials – all indications with high unmet need”

-Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex.

Anavex Life Sciences Corp. (NASDAQ: AVXL) is a biopharmaceutical company focused on using genetic medicine to treat neurodegenerative and neurodevelopmental diseases, such as Alzheimer’s disease

Read More